Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

Author:

Moreno Raúl,Díez José-Luis,Diarte José-Antonio,Salinas Pablo,de la Torre Hernández José María,Andres-Cordón Juan F.,Trillo Ramiro,Briales Juan Alonso,Amat-Santos Ignacio,Romaguera Rafael,Díaz José-Francisco,Vaquerizo Beatriz,Ojeda Soledad,Cruz-González Ignacio,Morena-Salas Daniel,Pérez de Prado Armando,Sarnago Fernando,Portero Pilar,Gutierrez-Barrios Alejandro,Alfonso Fernando,Bosch Eduard,Pinar Eduardo,Ruiz-Arroyo José-Ramón,Ruiz-Quevedo Valeriano,Jiménez-Mazuecos Jesús,Lozano Fernando,Rumoroso José-Ramón,Novo Enrique,Irazusta Francisco J.,García del Blanco Bruno,Moreu José,Ballesteros-Pradas Sara M.,Frutos Araceli,Villa Manuel,Alegría-Barrero Eduardo,Lázaro Rosa,Paredes Emilio

Abstract

Abstract Background During COVID-19 pandemic, elective invasive cardiac procedures (ICP) have been frequently cancelled or postponed. Consequences may be more evident in patients with diabetes. Objectives The objective was to identify the peculiarities of patients with DM among those in whom ICP were cancelled or postponed due to the COVID-19 pandemic, as well as to identify subgroups in which the influence of DM has higher impact on the clinical outcome. Methods We included 2,158 patients in whom an elective ICP was cancelled or postponed during COVID-19 pandemic in 37 hospitals in Spain. Among them, 700 (32.4%) were diabetics. Patients with and without diabetes were compared. Results Patients with diabetes were older and had a higher prevalence of other cardiovascular risk factors, previous cardiovascular history and co-morbidities. Diabetics had a higher mortality (3.0% vs. 1.0%; p = 0.001) and cardiovascular mortality (1.9% vs. 0.4%; p = 0.001). Differences were especially important in patients with valvular heart disease (mortality 6.9% vs 1.7% [p < 0.001] and cardiovascular mortality 4.9% vs 0.9% [p = 0.002] in patients with and without diabetes, respectively). In the multivariable analysis, diabetes remained as an independent risk factor both for overall and cardiovascular mortality. No significant interaction was found with other clinical variables. Conclusion Among patients in whom an elective invasive cardiac procedure is cancelled or postponed during COVID-19 pandemic, mortality and cardiovascular mortality is higher in patients with diabetes, irrespectively on other clinical conditions. These procedures should not be cancelled in patients with diabetes.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 78. Geneva: WHO; 2020. World Health Organization. Coronavirus disease. (COVID-19) Situation Report - 78. Geneva: WHO; 2019. p. 2020.

2. Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, Martín-Moreiras J, Rumoroso JR, López-Palop R, et al. On behalf of all the participants of the ACI-SEC Infarction Code Registry Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. Interv Cardiol. 2020;2:82–9.

3. Romaguera R, Cruz-González I, Jurado-Román A, Ojeda S, Fernández-Cisnal A, Jorge-Pérez P, et al. Considerations on the invasive management of ischemic and structural heart disease during the COVID-19 coronavirus outbreak. Consensus statement of the Interventional Cardiology Association and the Ischemic Heart Disease and Acute Cardiac Care Association of the Spanish Society of Cardiology. REC Interv Cardiol. 2020;2:106–11.

4. Rodríguez-Leor O, Cid-Álvarez B, de Prado A, Rossello X, Ojeda S, Serrador A, López-Palop R, Martín-Moreiras J, et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care The Spanish experience. Rev Esp Cardiol. 2020;73:994–1002.

5. Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Mauri Ferré J, Windecker S, Dudek D, Baumbach A. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. Eur Heart J. 2020;41:1839–51.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3